Leap Therapeutics, Inc. (LPTX) Touches $7.16 Formed H&S; 13 Analysts Covering Playtech plc (LON:PTEC)

Leap Therapeutics, Inc. (LPTX) formed inverse H&S with $7.73 target or 8.00% above today’s $7.16 share price. Leap Therapeutics, Inc. (LPTX) has $88.46M valuation. The stock increased 0.28% or $0.02 during the last trading session, reaching $7.16. About 78,417 shares traded or 11.47% up from the average. Leap Therapeutics, Inc. (NASDAQ:LPTX) has 0.00% since January 30, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 15 analysts covering Playtech Ltd (LON:PTEC), 13 have Buy rating, 0 Sell and 2 Hold. Therefore 87% are positive. Playtech Ltd had 144 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Playtech plc (LON:PTEC) has “Buy” rating given on Thursday, November 2 by Canaccord Genuity. The rating was maintained by Canaccord Genuity on Monday, October 5 with “Buy”. The stock of Playtech plc (LON:PTEC) earned “Buy” rating by Berenberg on Thursday, February 9. The stock of Playtech plc (LON:PTEC) has “Buy” rating given on Friday, February 19 by Deutsche Bank. The rating was maintained by Canaccord Genuity with “Buy” on Wednesday, May 18. The firm has “Overweight” rating by Morgan Stanley given on Thursday, June 16. The firm has “Buy” rating by UBS given on Monday, February 27. The stock has “Buy” rating by Shore Capital on Thursday, August 25. Canaccord Genuity maintained the shares of PTEC in report on Wednesday, March 23 with “Buy” rating. The firm has “Buy” rating by Investec given on Wednesday, August 2. See Playtech plc (LON:PTEC) latest ratings:

11/01/2018 Broker: Credit Suisse Rating: Outperform Old Target: GBX 980.00 New Target: GBX 980.00 Maintain
11/01/2018 Broker: Berenberg Rating: Hold Old Target: GBX 1000.00 New Target: GBX 950.00 DownGrade
08/01/2018 Broker: Morgan Stanley Rating: Overweight Old Target: GBX 1050.00 New Target: GBX 1050.00 Maintain
05/12/2017 Broker: Credit Suisse Rating: Outperform Old Target: GBX 1200.00 New Target: GBX 980.00 Maintain
16/11/2017 Broker: Deutsche Bank Rating: Buy Old Target: GBX 1060.00 New Target: GBX 1060.00 Maintain
13/11/2017 Broker: Berenberg Rating: Buy Old Target: GBX 1180.00 New Target: GBX 1000.00 Reiteration
13/11/2017 Broker: Deutsche Bank Rating: Buy Old Target: GBX 1060.00 New Target: GBX 1060.00 Maintain
03/11/2017 Broker: Morgan Stanley Rating: Overweight Old Target: GBX 1400.00 New Target: GBX 1050.00 Maintain
03/11/2017 Broker: Investec Rating: Buy Old Target: GBX 1120.00 New Target: GBX 1030.00 Reiteration
02/11/2017 Broker: Numis Securities Rating: Buy Old Target: GBX 1040.00 New Target: GBX 1040.00 Maintain

Playtech plc engages in the development and licensing of software products for the online and land gambling industries. The company has market cap of 2.50 billion GBP. The firm operated through Gaming and Financials divisions. It has a 9.27 P/E ratio. The Company’s gaming applications comprise online casino, poker and other P2P games, bingo, mobile and social gaming, land based terminal, sports betting, lottery, and casual and fixed-odds games.

The stock decreased 0.65% or GBX 5.2 during the last trading session, reaching GBX 795. About 100,521 shares traded. Playtech plc (LON:PTEC) has 0.00% since January 30, 2017 and is . It has underperformed by 16.70% the S&P500.

Analysts await Leap Therapeutics, Inc. (NASDAQ:LPTX) to report earnings on February, 12. After $-0.73 actual earnings per share reported by Leap Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 5.48% negative EPS growth.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: